Hindustan Organic Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 1:47 am

Competitors of Hindustan Organic Chemicals Ltd

All Competitor Stocks of Hindustan Organic Chemicals Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:45 pm

Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 163.89 Cr.. The value appears strong and on an upward trend. It has increased from 136.62 Cr. (Mar 2025) to 163.89 Cr., marking an increase of 27.27 Cr..
• For Expenses, as of Jun 2025, the value is 177.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 173.37 Cr. (Mar 2025) to 177.31 Cr., marking an increase of 3.94 Cr..
• For Operating Profit, as of Jun 2025, the value is -13.42 Cr.. The value appears strong and on an upward trend. It has increased from -36.75 Cr. (Mar 2025) to -13.42 Cr., marking an increase of 23.33 Cr..
• For OPM %, as of Jun 2025, the value is -8.19%. The value appears strong and on an upward trend. It has increased from -26.90% (Mar 2025) to -8.19%, marking an increase of 18.71%.
• For Other Income, as of Jun 2025, the value is 12.62 Cr.. The value appears to be declining and may need further review. It has decreased from 550.76 Cr. (Mar 2025) to 12.62 Cr., marking a decrease of 538.14 Cr..
• For Interest, as of Jun 2025, the value is 4.98 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -9.60 Cr. (Mar 2025) to 4.98 Cr., marking an increase of 14.58 Cr..
• For Depreciation, as of Jun 2025, the value is 0.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.35 Cr. (Mar 2025) to 0.44 Cr., marking an increase of 0.09 Cr..
• For Profit before tax, as of Jun 2025, the value is -6.22 Cr.. The value appears to be declining and may need further review. It has decreased from 523.26 Cr. (Mar 2025) to -6.22 Cr., marking a decrease of 529.48 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 0.64% (Mar 2025) to 0.00%, marking a decrease of 0.64%.
• For Net Profit, as of Jun 2025, the value is -6.22 Cr.. The value appears to be declining and may need further review. It has decreased from 519.93 Cr. (Mar 2025) to -6.22 Cr., marking a decrease of 526.15 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.94. The value appears to be declining and may need further review. It has decreased from 77.39 (Mar 2025) to -0.94, marking a decrease of 78.33.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:57 pm

Balance Sheet

Last Updated: September 10, 2025, 3:52 pm

Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 67.00 Cr..
• For Reserves, as of Mar 2025, the value is 978.00 Cr.. The value appears strong and on an upward trend. It has increased from -119.00 Cr. (Mar 2024) to 978.00 Cr., marking an increase of 1,097.00 Cr..
• For Borrowings, as of Mar 2025, the value is 219.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,362.00 Cr. (Mar 2024) to 219.00 Cr., marking a decrease of 1,143.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 304.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 264.00 Cr. (Mar 2024) to 304.00 Cr., marking an increase of 40.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,568.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,575.00 Cr. (Mar 2024) to 1,568.00 Cr., marking a decrease of 7.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 227.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2024) to 227.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,349.00 Cr. (Mar 2024) to 1,336.00 Cr., marking a decrease of 13.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,568.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2024) to 1,568.00 Cr., marking a decrease of 7.00 Cr..

Notably, the Reserves (978.00 Cr.) exceed the Borrowings (219.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
• For Diluted EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
• For Cash EPS (Rs.), as of Mar 25, the value is 58.51. This value is within the healthy range. It has increased from -7.83 (Mar 24) to 58.51, marking an increase of 66.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 79.66. It has decreased from 104.64 (Mar 24) to 79.66, marking a decrease of 24.98.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -9.42. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to -9.42, marking a decrease of 11.75.
• For PBIT / Share (Rs.), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 0. It has decreased from 2.12 (Mar 24) to -9.67, marking a decrease of 11.79.
• For PBT / Share (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from -8.22 (Mar 24) to 58.70, marking an increase of 66.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 58.27. This value is within the healthy range. It has increased from -8.04 (Mar 24) to 58.27, marking an increase of 66.31.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.24. This value is within the healthy range. It has increased from -8.12 (Mar 24) to 58.24, marking an increase of 66.36.
• For PBDIT Margin (%), as of Mar 25, the value is -11.82. This value is below the healthy minimum of 10. It has decreased from 2.22 (Mar 24) to -11.82, marking a decrease of 14.04.
• For PBIT Margin (%), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 10. It has decreased from 2.02 (Mar 24) to -12.13, marking a decrease of 14.15.
• For PBT Margin (%), as of Mar 25, the value is 73.68. This value is within the healthy range. It has increased from -7.85 (Mar 24) to 73.68, marking an increase of 81.53.
• For Net Profit Margin (%), as of Mar 25, the value is 73.14. This value exceeds the healthy maximum of 10. It has increased from -7.68 (Mar 24) to 73.14, marking an increase of 80.82.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 73.11. This value exceeds the healthy maximum of 20. It has increased from -7.76 (Mar 24) to 73.11, marking an increase of 80.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 37.47. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.47, marking an increase of 37.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to -5.43, marking a decrease of 19.65.
• For Return On Assets (%), as of Mar 25, the value is 25.04. This value is within the healthy range. It has increased from -3.47 (Mar 24) to 25.04, marking an increase of 28.51.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -0.04 (Mar 24) to 0.00, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from -16.20 (Mar 24) to 0.19, marking an increase of 16.39.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has increased from 0.91 (Mar 24) to 3.61, marking an increase of 2.70.
• For Quick Ratio (X), as of Mar 25, the value is 3.46. This value exceeds the healthy maximum of 2. It has increased from 0.86 (Mar 24) to 3.46, marking an increase of 2.60.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.48 (Mar 24) to 6.84, marking a decrease of 1.64.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -1.48. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 24) to -1.48, marking a decrease of 1.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -1.59, marking a decrease of 1.79.
• For Enterprise Value (Cr.), as of Mar 25, the value is 201.55. It has decreased from 807.36 (Mar 24) to 201.55, marking a decrease of 605.81.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.37, marking a decrease of 0.78.
• For EV / EBITDA (X), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has decreased from 51.44 (Mar 24) to -3.18, marking a decrease of 54.62.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
• For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from -5.13 (Mar 24) to 0.27, marking an increase of 5.40.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
• For EarningsYield, as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 1.37, marking an increase of 1.57.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness